NL-OMON31630撤回不适用
The Split Dose Study: Split dose Rhenium-188-HEDP regimen in hormone refractory prostate cancer patients with bone metastases; a phase I toxicity study and phase II efficacy study. - The Split Dose Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Histologically documented prostate carcinoma; presence of osteoblastic bone metastases; hormone refractory disease; bone pain; life expectancy of at least 3 months; informed consent.
排除标准
- •Previous chemotherapy within 6 weeks prior to screening; prior treatment with systemic radiotherapeutic bone agent within a specified period; previous external beam radiotherapy within a specified period; active CNS or epidural metastases. ANC < 2 EXP9/L; Platelet count < 150 EXP9/L; Hb < 6 mmol/L; PSA > 5 microgram/L.
研究者
相似试验
进行中（未招募）
不适用
The Split Dose Study: Split dose Rhenium-188-HEDP regimen in hormone refractory prostate cancer patients with bone metastases; a phase I toxicity study and phase II efficacy study. - The Split Dose StudyEUCTR2007-004545-15-NLniversity Medical Center Utrecht
已完成
不适用
Effectiveness of 2-liter split-dose polyethylene glycol versus 2-liter non-split-dose polyethylene glycol for bowel preparation in colonoscopyColon cancerTCTR20160609005The Gastrointestinal Association of Thailand180
已完成
3 期
Efficacy of Split-Dose versus Single Dose of Ergocalciferol on Serum 25(OH)D in CAPD Patient: A Randomized Controlled TrialCAPD patientinclusion criteria were CAPD patient with dialysis before enrolled for at least three months,aged > 18 years,who were diagnosed vitamin D deficiency and insufficiency,defined by vitamErgocalciferol,Vitamin D deficiency,Vitamin D insufficiency CAPD,Single dose,Split doseTCTR20200821005one50
招募中
不适用
Efficacy of split-dosing versus nonsplit-dosing of ergocalciferol on serum 25-hydroxyvitamin D in chronic kidney disease patientsvitamin D def/insuff in chronic kidney disease patientsTCTR20190830003Phramongkutklao Hospital76
招募中
不适用
HYpofractionated, Dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinomaHead and neck squamous cell carcinoma10027655NL-OMON53777Erasmus MC, Universitair Medisch Centrum Rotterdam154